Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

33%

3 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

4(50.0%)

Phase 3

2(25.0%)

Phase 2

1(12.5%)

Phase 4

1(12.5%)

8Total

N/A(4)

Phase 3(2)

Phase 2(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06041997Not ApplicableRecruiting

Smartphone Use Restriction as Treatment of Primary Headache

Role: collaborator

NCT01917604Not ApplicableUnknown

Oral Health Related Quality of Life and Clinical Outcomes in Patients Undergoing Canine Disimpaction

Role: collaborator

NCT04347174Not ApplicableCompleted

A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients

Role: collaborator

NCT04358809Phase 3Unknown

Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill

Role: collaborator

NCT04353518Phase 3Unknown

Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19

Role: collaborator

NCT00399204Phase 4Withdrawn

Comparison of Cardiovascular Outcomes of Pioglitazone and Metformin in Type 2 Diabetes Patients

Role: collaborator

NCT00836836Phase 2Completed

Modified Atkins Diet in Childhood Epilepsy

Role: collaborator

NCT03187158Unknown

Factors Affecting Early Adult Lung Function

Role: lead

NCT00889018Not ApplicableUnknown

Trial Comparing Two Carboplatin Doses in Groups C and D Intraocular Retinoblastoma

Role: collaborator

All 9 trials loaded